MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
117<br />
“<strong>ME</strong>/CFS describes a disorder of chronic debilitat<strong>in</strong>g fatigue that cannot be expla<strong>in</strong>ed by any known medical or<br />
psychological condition. The Cochrane Collaboration advises practitioners to implement graded exercise<br />
therapy for patients with <strong>ME</strong>/CFS, us<strong>in</strong>g cognitive behavioural pr<strong>in</strong>ciples. CBT represents a psychological<br />
and physical <strong>in</strong>tervention approach aimed at assist<strong>in</strong>g <strong>in</strong>dividuals <strong>in</strong> re‐evaluat<strong>in</strong>g concepts related to<br />
their illness and <strong>in</strong> adopt<strong>in</strong>g thoughts and behaviours designed to promote recovery (the reference for this<br />
statement is Chalder, Deale and Wessely et al. Am J Med 1995:98:419‐420). This approach to GET advises<br />
patients to cont<strong>in</strong>ue exercis<strong>in</strong>g at the same level even when they develop symptoms <strong>in</strong> response to exercise<br />
(two references are provided for this statement, one be<strong>in</strong>g Fulcher KY and White PD, BMJ 1997:314:1647‐<br />
1652 – this be<strong>in</strong>g one of the RCTs based on the Oxford criteria that the GDG relied upon for its<br />
recommendation of GET. The other reference was Clark LV and White PD (J Mental Health 2005: 14: 237‐<br />
252), <strong>in</strong> which Clark and White state that patients with <strong>ME</strong>/CFS are de‐conditioned, and argue that: “Patient<br />
education is necessary to <strong>in</strong>form patients of the positive benefit / risk ratio <strong>in</strong> order to improve acceptance and<br />
adherence”). Nijs et al cont<strong>in</strong>ue: “Conversely, there is evidence of immune dysfunction <strong>in</strong> <strong>ME</strong>/CFS, and<br />
research shows further deregulation of the immune system <strong>in</strong> response to too‐vigorous exercise, lead<strong>in</strong>g to<br />
an <strong>in</strong>crease <strong>in</strong> fatigue and post‐exertional malaise. It has been shown that even a 30% <strong>in</strong>crease <strong>in</strong> activity<br />
frequently triggers a relapse (ref: Black CD, O’Connor, McCully K. Dynamic Medic<strong>in</strong>e 2005:4:3). The severe<br />
exacerbation of symptoms follow<strong>in</strong>g exercise, as seen <strong>in</strong> patients with <strong>ME</strong>/CFS, is not present <strong>in</strong> other<br />
disorders where fatigue is a predom<strong>in</strong>ant symptom. This post‐exertional malaise is a primary characteristic<br />
evident <strong>in</strong> up to 95% of people with <strong>ME</strong>/CFS. It is possible that exercise at <strong>AN</strong>Y <strong>in</strong>tensity that exceeds an<br />
<strong>ME</strong>/CFS patient’s physical capabilities may result <strong>in</strong> the worsen<strong>in</strong>g of symptoms. Early approaches to GET<br />
advised patients to cont<strong>in</strong>ue exercis<strong>in</strong>g at the same level when they developed symptoms <strong>in</strong> response to the exercise.<br />
This led to exacerbation of symptoms and adverse feedback from patients and patient charities”.<br />
In 2008 a paper by Professor Julia Newton et al (Holl<strong>in</strong>gsworth JG, Newton JL et al; Cl<strong>in</strong> Gastroenterol<br />
Hepatol 2008:6:(9):1041‐1048) compared mitochondrial function <strong>in</strong> patients with primary biliary cirrhosis<br />
(PBC), patients with primary scleros<strong>in</strong>g cholangitis, patients with <strong>ME</strong>/CFS and normal controls; the authors<br />
stated that PBC is characterised <strong>in</strong> 95% of patients by autoantibody responses directed aga<strong>in</strong>st the<br />
mitochondrial antigen pyruvate dehydrogenase complex (PDC). To def<strong>in</strong>e mitochondrial function <strong>in</strong><br />
peripheral muscle dur<strong>in</strong>g exercise, (31)P magnetic resonance spectroscopy was used.<br />
Whilst the paper is chiefly concerned with mitochondrial dysfunction <strong>in</strong> patients with primary biliary<br />
cirrhosis (and the results clearly <strong>in</strong>dicate mitochondrial dysfunction <strong>in</strong> patients with PBC, who showed<br />
excess muscle acidosis at higher levels of exercise), the authors state about <strong>ME</strong>/CFS patients: “Interest<strong>in</strong>gly,<br />
prolonged time to maximum proton efflux was also seen <strong>in</strong> the (<strong>ME</strong>)CFS control group, <strong>in</strong>dicat<strong>in</strong>g that there are<br />
aspects of muscle pH handl<strong>in</strong>g that are abnormal <strong>in</strong> this important cl<strong>in</strong>ical group”.<br />
Professor Newton is Lead Cl<strong>in</strong>ician <strong>in</strong> the <strong>in</strong>ternationally renowned Cardiovascular <strong>Invest</strong>igations Unit at<br />
the University of Newcastle, UK, which is the largest autonomic function test<strong>in</strong>g laboratory <strong>in</strong> Europe; her<br />
work focuses on the role of the autonomic nervous system <strong>in</strong> the development of fatigue, specifically <strong>in</strong><br />
primary biliary cirrhosis, but also <strong>in</strong> the pathogenesis of fatigue <strong>in</strong> <strong>ME</strong>/CFS. In her Conference pack for the<br />
<strong>ME</strong> Research UK International Research Conference held at the University of Cambridge on 6 th May 2008,<br />
Professor Newton said: “Recent results from a series of MR scans have shown impaired proton removal from muscle<br />
dur<strong>in</strong>g exercise <strong>in</strong> patients with <strong>ME</strong>/CFS compared to matched controls. This has led us to hypothesise that fatigue<br />
arises due to impaired pH run off from muscle dur<strong>in</strong>g exercise which is <strong>in</strong>fluenced by the degree of autonomic<br />
dysfunction”.<br />
In 2009, Light et al published evidence demonstrat<strong>in</strong>g that after moderate exercise, (<strong>ME</strong>)CFS and (FM)CFS<br />
patients show enhanced gene expression for receptors detect<strong>in</strong>g muscle metabolites and that these were<br />
highly correlated with symptoms of both physical and mental fatigue and pa<strong>in</strong>. The marked alterations <strong>in</strong><br />
gene expression from circulat<strong>in</strong>g leucocytes of (<strong>ME</strong>)CFS patients after exercise suggest that such alterations<br />
could be used as objective biomarkers, with ~ 90% of the (<strong>ME</strong>)CFS patients be<strong>in</strong>g dist<strong>in</strong>guishable from<br />
controls us<strong>in</strong>g four of the genes measured. The authors have shown that 25 m<strong>in</strong>utes of moderate exercise<br />
generates large and rapid <strong>in</strong>creases <strong>in</strong> gene expression <strong>in</strong> leucocytes of (<strong>ME</strong>)CFS subjects but not <strong>in</strong> control